Infect. Immun., 02 1997, 604-608, Vol 65, No. 2
Copyright © 1997, American Society for Microbiology

Helicobacter pylori lipopolysaccharide can activate 70Z/3 cells via CD14

T Kirkland, S Viriyakosol, GI Perez-Perez and MJ Blaser
Department of Pathology, University of California School of Medicine, San Diego 92161, USA.

Helicobacter pylori persistently colonizes the human gastrointestinal tract and is associated with chronic gastritis and, in some cases, peptic ulcer disease or gastric neoplasms. One factor in the persistence of this organism may be its inability to elicit a strong inflammatory response. Lipopolysaccharide (LPS) is a proinflammatory substance found in the cell walls of all gram-negative bacteria. H. pylori LPS has been found by several different measures to be less active than LPS from Enterobacteriaceae. This study addresses the role of CD14 and LPS-binding protein in the cellular response to H. pylori LPS. We report that H. pylori LPS activates mammalian cells expressing CD14 at much lower LPS concentrations than those for control cells not expressing CD14. The maximal activation of CD14-70Z/3 cells by H. pylori LPS also requires LPS-binding protein. H. pylori LPS at concentrations as high as 30 microg/ml does not elicit an interleukin-8 (IL-8) response from the epithelial cell line SW620 in the presence of CD14; 10 ng of Escherichia coli LPS per ml elicits a maximal IL-8 response. Furthermore, in contrast to some other types of LPS with little activity, H. pylori LPS does not inhibit the CD14-70Z/3 cell response to E. coli LPS. From these studies, we conclude that H. pylori LPS, though much less active than E. coli LPS, stimulates cells via CD14.

This article has been cited by other articles:

• Durkin, E., Moran, A. P., Hanson, P. J. (2006). Apoptosis induction in gastric mucous cells in vitro: lesser potency of Helicobacter pylori than Escherichia coli lipopolysaccharide, but positive interaction with ibuprofen. Innate Immunity 12: 47-56 [Abstract]  
• SALGADO, F., GARCIA, A., ONATE, A., GONZALEZ, C., KAWAGUCHI, F. (2002). Increased in-vitro and in-vivo biological activity of lipopolysaccharide extracted from clinical low virulence vacA genotype Helicobacter pylori strains. J Med Microbiol 51: 771-776 [Abstract] [Full Text]  
• Innocenti, M., Svennerholm, A.-M., Quiding-Jarbrink, M. (2001). Helicobacter pylori Lipopolysaccharides Preferentially Induce CXC Chemokine Production in Human Monocytes. Infect. Immun. 69: 3800-3808 [Abstract] [Full Text]  
• Kodaira, H., Mizoroki, T., Shimada, H., Ishii, K., Hosono, M., Kumazawa, Y. (1999). Potential role of bacterial lipopolysaccharides in the development of autoimmune gastritis induced by neonatal thymectomy. Innate Immunity 5: 269-278 [Abstract]  
• Bliss, C. M. Jr., Golenbock, D. T., Keates, S., Linevsky, J. K., Kelly, C. P. (1998). Helicobacter pylori Lipopolysaccharide Binds to CD14 and Stimulates Release of Interleukin-8, Epithelial Neutrophil-Activating Peptide 78, and Monocyte Chemotactic Protein 1 by Human Monocytes. Infect. Immun. 66: 5357-5363 [Abstract] [Full Text]